Print this Page
News
Fox Chase Donor Receives Distinguished Honor
PHILADELPHIA (November 17, 1998) -- Fox Chase Cancer Center has the honor to be the nominator of this year's recipient of the National Society of Fund Raising Executives' (NSFRE) Outstanding Corporation of the Year Award. Crown Cork & Seal Company, Inc. was honored at the NSFRE's Awards Luncheon, Monday, November 16.
Crown Cork and Seal was chosen as this year's winner for its outstanding philanthropic efforts. This major international corporation in Northeast Philadelphia has made substantial contributions to Fox Chase Cancer Center and to many other worthy health, education and community organizations in our region. The company is led by chairman and CEO William J. Avery.
"Fox Chase has been fortunate to be the beneficiary of Crown Cork & Seal's philanthropy over the past five years," said Sandra W. Weckesser, Esq., vice president for institutional advancement. "Crown Cork & Seal has made several generous capital and program awards to the Center and has taken a leadership position in support of a number of special events as well."
Crown Cork and Seal employees have both participated in and volunteered for leadership roles at Fox Chase special events. Weckesser added, "Mr. Avery has been a tireless and energetic member of the Fox Chase Board of Directors. He has enthusiastically undertaken additional responsibilities as chairman of a major special event, chairman of the Institutional Advancement Committee, and chairman of our current five-year $38 million capital campaign to build the Research Institute for Cancer Prevention of Fox Chase Cancer Center."
Awards are bestowed annually to Fund Raising Volunteer of the Year, Individual Philanthropist of the Year, Outstanding Foundation of the Year, Outstanding Corporation of the Year and Fund Raising Executive of the Year.
Fox Chase Cancer Center is one of 34 National Cancer Institute-designated comprehensive cancer centers in the nation. Fox Chase activities include basic and clinical research; prevention, detection, and treatment of cancer; and community outreach programs.
Fox Chase Cancer Center, part of Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase also was among the first institutions to receive the National Cancer Institute’s prestigious comprehensive cancer center designation in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are routinely recognized in national rankings, and the Center’s nursing program has achieved Magnet status for excellence three consecutive times. Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research and oversees programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX-CHASE (1-888-369-2427).
